Developer docs
API playgroundTry for free, no card

Search company profiles

Sami-Sabinsa Group

Full company profile

uuid0009kcn

Namestring
Sami-Sabinsa Group
Legal namestring
Sami-Sabinsa Group Limited
Company typeenum
Private
Founded yearint
1991
Descriptiontext

Sami-Sabinsa Group Limited is a Bangalore-headquartered, family-controlled manufacturer of standardized botanical extracts, nutraceuticals, cosmeceuticals, probiotics, enzymes, and specialty fine chemicals serving nutraceutical, pharmaceutical, cosmetic, and food & beverage manufacturers globally. The company's portfolio centers on patented, clinically documented branded ingredients—most prominently Curcumin C3 Complex (263+ publications, 109 clinical studies), BioPerine (95% piperine, 63 bioavailability studies), LactoSpore (GRAS-affirmed Heyndrickxia coagulans MTCC 5856), ForsLean, Gugulipid, Selenium SeLECT, Sabroxy, and Cosmoperine—protected by 500+ granted patents and 300+ pending applications across major jurisdictions. Sami-Sabinsa holds 100+ national and international awards including the 2024 Ellis Island Medal of Honor and the 2023 Varro E. Tyler Award from the American Botanical Council, reflecting its industry standing.

Operationally, Sami-Sabinsa runs eight cGMP-certified manufacturing facilities (seven in Karnataka and Telangana, India; one in Payson, Utah) and a 40,000-acre contract farming program across India, Southeast Asia, and Africa involving 5,000+ farmers under buyback agreements. Core technology platforms include Super Critical Fluid (CO2) Extraction at the Nelamangala Bengaluru facility, a continuous stainless-steel-316 extraction line at Dobaspet rated at 40+ tonnes/day of herbal raw material, and nine in-house R&D divisions (Natural Drugs, Phytochemistry, Synthetic Chemistry, Tissue Culture, Biotechnology, Analytical R&D, Biological Research, Microbiology, Formulation R&D) staffed by 120+ scientists. Certifications across ISO 22000, FSSC 22000, NSF GMP, USP GMP, FAMI-QS, Non-GMO Project, FSSAI, FSRN, and Halal/Kosher enable cross-jurisdictional regulatory access.

The company monetizes through a direct B2B sales model via 14 wholly-owned subsidiaries across 19 countries (USA, India, Australia, Brazil, Canada, China, Germany, Japan, Poland, South Africa, South Korea, UAE, Vietnam) with quote-based pricing and multi-year manufacturer contracts. Revenue streams include ingredient sales (nutraceutical and cosmeceutical), patent licensing of branded ingredients, cGMP contract manufacturing in India and the USA, and contract research services. The group was founded in 1991 by the late Dr. Muhammed Majeed (with Sabinsa Corporation founded in the USA in 1988) and is now led by Dr. Anju Majeed (Group Executive Chairperson) and Shaheen Majeed (Global CEO & MD), with ownership and control remaining within the Majeed family. The group rebranded from Sami Labs Limited to Sami-Sabinsa Group Limited in 2025 and acquired Nature's Formulary on 2025-02-04.

Short descriptiontext

Sami-Sabinsa Group is a Bangalore-headquartered, family-controlled manufacturer of standardized herbal extracts, nutraceuticals, cosmeceuticals, and specialty chemicals for the pharmaceutical, food, and personal care industries, serving global manufacturers across 19 countries via 14 wholly-owned subsidiaries and a 500+ patent portfolio.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBangalore, India
HQ citystring
Bangalore
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices16 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
standardized herbal extracts, nutraceutical ingredients, cosmeceutical actives, probiotic postbiotic blends, specialty fine chemicals
Industry2 codes
1Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin)
CodeAFAJAKAKPrimaryYes
2Probiotics & Digestive Health Supplements
CodeCRADAGAFPrimaryNo
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Nutraceutical and Cosmeceutical Ingredients
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Nutraceutical Ingredients
TypeHardware Sales
Description

Sale of standardized phyto extracts, enzymes, probiotics, prebiotics, postbiotics, minerals, and nutritional fine chemicals to dietary supplement manufacturers

sami-sabinsagroup.com
2Cosmeceutical Ingredients
TypeHardware Sales
Description

Supply of natural actives, peptides, anti-glycation ingredients, dermaceuticals, and nutricosmetics to personal care and cosmetics manufacturers

sami-sabinsagroup.com
3Patent Licensing
TypeLicensing Royalties
Description

Licensing of patented products and proprietary formulations including Curcumin C3 Complex, BioPerine, LactoSpore, ForsLean, and other branded ingredients

sami-sabinsagroup.com
4Contract Manufacturing
TypeProfessional Services
Description

Custom manufacturing services at cGMP certified facilities in India and USA for nutraceutical and pharmaceutical ingredients

sami-sabinsagroup.com
5Contract Research Services
TypeProfessional Services
Description

R&D services including synthesis, phytochemistry, biotechnology research, tissue culture, and analytical method development for external clients

sami-sabinsagroup.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure
Pricing details1 tier
1B2B bulk ingredient supply with custom formulation capabilities
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing; no public pricing available as company sells directly to manufacturers and formulation companies

sami-sabinsagroup.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 15 records shown
1Curcumin C3 Complex
Description

Patented composition of curcuminoids from turmeric rhizomes, extensively studied with 263+ publications including 109 clinical studies

sami-sabinsagroup.com
+14 more records
Core offering1 text field

Sami-Sabinsa Group manufactures and markets standardized herbal extracts, nutraceutical and cosmeceutical ingredients (including Curcumin C3 Complex, BioPerine, LactoSpore, ForsLean, Boswellin), probiotics, postbiotics, enzymes, multi-enzyme blends, minerals, peptides, and specialty fine chemicals. It sells these patented, clinically validated ingredients to dietary supplement, pharmaceutical, food and beverage, and personal care manufacturers through its own direct sales network across 19 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 500+ US and International patents awarded
+4 more records
Product overview1 text field

Sami-Sabinsa Group is a research-focused multinational health science company that manufactures and markets a comprehensive portfolio of patented nutraceutical and cosmeceutical ingredients. The company's product ecosystem centers on its core offerings: Standardized Phyto Extracts (featuring flagship brands like Curcumin C3 Complex®, BioPerine®, ForsLean®, Boswellin®, Gugulipid®, and Shagandha™), complemented by Super Critical Fluid (SCF) Extracts using eco-friendly CO2 extraction technology, and a complete biotics portfolio including LactoSpore®, ImmunoSpore™, LactoWise®, and LactoCran® under the Prebiotics, Probiotics, Postbiotics & Synbiotics category. The company also offers Phyto Functional Blends (LeanGard®, HotSip®, LivLonga®, Metabolicgard®, NiLitis® SR, Selendrovir™, WithanAlpha™) that combine multiple patented ingredients for targeted health benefits, and the Geroceuticals™ line for healthy aging. Supporting these core products are Cosmeceutical Ingredients including Natural Actives, Peptides (Olepent®, Oletrip®), Anti-glycation, Dermaceuticals, Nutricosmetics, and Specialty Chemicals. The portfolio spans over 120 products across 8 manufacturing units, supported by Contract Farming services for sustainable raw material sourcing and Contract Research capabilities for custom development. Notable branded products include: Curcumin C3 Complex® (95% Curcuminoids, 263+ publications), BioPerine® (95% Piperine, bioavailability enhancer), LactoSpore® (spore-forming probiotic), Selenium SeLECT® (L-Selenomethionine), Boswellin® (Boswellia serrata extracts), ForsLean® (Coleus forskohlii, 10-40% Forskolin), Gugulipid® (Commiphora mukul), Shagandha™ (Ashwagandha), Saberry® (Amla/Emblica), Cococin® (Coconut), Silbinol® (Pterocarpus), and SabiWhite® (Tetrahydrocurcumin).

Product and service15 records
1Standardized Phyto Extracts
CategoryNutraceutical Ingredients
Description

A comprehensive range of standardized herbal extracts including Curcumin C3 Complex®, BioPerine®, ForsLean®, Boswellin®, Gugulipid®, Shagandha™ and other botanical ingredients with standardized active compound concentrations for nutraceutical and pharmaceutical manufacturers.

2Super Critical Fluid (SCF) Extracts
CategoryNutraceutical Ingredients
Description

Eco-friendly CO2-based botanical extracts including Nigellin® Black Cumin extracts, Ginger SCF Extract, Turmeric SCF Extract, and Guggul SCF Extract (Gugulipid®) with intact bio-potency for nutraceutical manufacturers.

3Phytochemicals for Nutritional Use
CategoryNutraceutical Ingredients
Description

Pure phytochemical compounds including Calebin A (CurCousin™), Resveratrol (Resvenox®), Oxyresveratrol (OxyResvenox®), Forskolin Carbonate, Diindolylmethane (DIM), and Indole-3-Carbinol for functional nutrition applications.

4Specialty Chemicals - Nutraceuticals
CategorySpecialty Chemicals
Description

Specialty fine chemicals including Eflornithine Hydrochloride, chiral drug intermediates, and custom synthesis for nutritional and pharmaceutical applications.

5Nutritional Fine Chemicals
CategoryNutraceutical Ingredients
Description

Fine chemicals for nutritional applications including amino acid derivatives, specialized intermediates, and research chemicals.

6Multi-enzyme Blends
CategoryNutraceutical Ingredients
Description

DigeZyme® and DigeZyme® EC enzyme blends combining α-Amylase, Cellulase, Lactase, Lipase, and Neutral protease for digestive health supplement manufacturers.

7Prebiotics, Probiotics, Postbiotics & Synbiotics
CategoryNutraceutical Ingredients
Description

Complete biotics portfolio including LactoSpore® (Heyndrickxia coagulans MTCC 5856), ImmunoSpore™, LactoWise®, LactoCran®, FenuFibers®, Fenumannan®, and Starmeric® for gut health and microbiome support.

8Minerals for Nutritional Use
CategoryNutraceutical Ingredients
Description

Bioavailable mineral compounds including Selenium SeLECT®, MethySelene®, SelenoForce®, Zinc Citrate, Zinc Monomethionine, Magnesium compounds, and Vanadium forms.

9GRAS Affirmed Products
CategoryNutraceutical Ingredients
Description

Products with FDA Generally Recognized As Safe status including BioPerine®, Curcumin C3 Complex®, Citrin K®, Cococin™, LactoSpore®, Saberry®, Selenium SeLECT®, CurCousin™, and Curcumin C3 Reduct®.

10Geroceuticals™
CategoryNutraceutical Ingredients
Description

Healthy aging ingredient line including Shagandha™ (Ashwagandha), Nigellin® Black Cumin extracts, Bacopin® (Brahmi), Silbinol® (Pterocarpus), Sabroxy® (Oroxylum), Centellin® (Gotu Kola), and Tinofolin® (Guduchi) for longevity and cognitive health.

11Phyto Functional Blends
CategoryNutraceutical Ingredients
Description

Proprietary combination products including LeanGard®, HotSip®, LivLonga®, Metabolicgard®, NiLitis® SR, OmegaMax, Selendrovir™, WithanAlpha™, and ZeaLutein® for targeted health benefits.

12Natural Actives
CategoryCosmeceutical Ingredients
Description

Cosmeceutical natural active ingredients including Saberry® (Amla), Boswellin® CG (Boswellia), Bacopin® (Brahmi), Centellin® CG (Gotu Kola), Venocin® (Horse Chestnut), Silbinol® (Pterocarpus), SabiWhite® (Tetrahydrocurcumin), and Cosmoperine® (Tetrahydropiperine).

13Peptides
CategoryCosmeceutical Ingredients
Description

Bioactive peptides including Olepent® (Oleanoyl sh-Pentapeptide-4), Oletrip® (Oleanoyl tripeptide), and PeptiSeLect® (Methylseleno Carboxypropylglutamine) for skin care and anti-aging applications.

14Contract Farming Service
CategoryServices
Description

Sustainable sourcing service through contract cultivation of medicinal plants across 40,000+ acres in India, Southeast Asia, and Africa, supporting Good Agricultural Practices and ensuring raw material quality supply for the group's manufacturing operations.

15Contract Research Service
CategoryServices
Description

Comprehensive R&D services including synthesis of organic molecules, chiral synthesis, SCFE, biotechnology research, phytochemistry, tissue culture, biochemical analysis, cosmetic claim substantiation, and pilot plant scale-up, offered in collaboration with IISc, IIT-Mumbai, IICT-Hyderabad, and UICT-Mumbai.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierFlagshipTypeGTM or Marketing PartnerAnnounced on2026-06-01
Description

Sami-Sabinsa Group served as Presenting Partner for The Hindu Huddle on Campus event at Amity University Bengaluru and the main two-day The Hindu Huddle conclave. The partnership supports youth engagement platform focusing on contemporary issues and provides visibility for the company's brand in India.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-05-01
Description

Sami-Sabinsa Group and Kerry Inc. jointly challenged FSSAI advisory restricting use of Ashwagandha leaves in dietary supplements, filing petitions at Karnataka High Court. Both companies sought to quash the advisory that prohibited use of leaves and leaf extracts, arguing it required formal regulation amendment. The court granted interim relief staying the ban for both petitioners.

Strategic tierFlagshipTypeGTM or Marketing PartnerAnnounced on2026-05-01
Description

Presenting Partner for The Hindu Huddle conference themed 'A World in Transition' bringing together ministers, ambassadors, MPs, and artists for discussions on geopolitics, AI, and democracy.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Contract farming partnerships with thousands of farmers across India, particularly in Tamil Nadu, Karnataka, and other states. Farmers receive planting supplies, training, buyback agreements, and guaranteed prices for cultivating medicinal plants. The model extends to Southeast Asian countries and Africa.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Sabinsa Corporation is an Industrial Associate Program (IAP) member of Princeton University, enabling access to sophisticated instruments including X-ray crystallography for research purposes.

6IIT Mumbai
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Collaborative research partnerships with Indian Institute of Technology Mumbai for process and method development.

sami-sabinsagroup.com
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Collaborative research with Indian Institute of Chemical Technology for key process development.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Collaborative research with Indian Institute of Science for advanced analytical capabilities and research support.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Academic collaboration for research and development in pharmaceutical technology.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Italian-based global leader in standardized botanical extracts and active pharmaceutical ingredients derived from plants. Directly comparable B2B ingredient manufacturer with a similar scientific, patented ingredient, and contract farming/procurement model.

TypeDirect peer
Description

Mumbai-headquartered supplier of carotenoids, botanical extracts, and specialty nutraceutical ingredients. Closest Indian peer with overlapping product categories (vision health, cognition, immunity) and similar branded-ingredient go-to-market model.

TypeDirect peer
Description

Germany-based global supplier of botanical extracts, tea, and plant-based ingredients for the food, beverage, nutraceutical, and pharmaceutical industries. Directly comparable in scale, scientific approach, and vertically integrated raw material sourcing.

TypeBroad incumbent
Description

Now part of Givaudan, Naturex is a broad-based natural ingredients supplier across food, beverage, nutrition, and personal care. Broader portfolio than Sami-Sabinsa but overlapping in standardized plant extracts and nutraceutical actives.

TypeBroad incumbent
Description

Privately held US ingredient manufacturer serving animal nutrition, human nutrition, and personal care with proprietary molecules. Comparable in scientific differentiation and proprietary ingredient focus, though broader in end-market coverage.

TypeBroad incumbent
Description

Ireland-headquartered global taste and nutrition company with a substantial nutraceutical ingredients business. Already a Sami-Sabinsa legal co-petitioner (Ashwagandha FSSAI case) and an overlapping competitor in functional food and supplement ingredients.

TypeDirect peer
Description

US-based manufacturer of botanical extracts serving the cosmetic, personal care, and nutraceutical markets. Comparable in standardized herbal extract offering and B2B ingredient distribution model, though smaller in scale.

TypeDirect peer
Description

China/US-based producer of high-purity botanical extracts and natural sweeteners (including stevia, monk fruit, and polyphenols) for nutrition and food applications. Directly comparable in standardized polyphenol extract manufacturing and global ingredient distribution.

TypeEmerging player
Description

China-based producer of standardized botanical extracts (green tea, grape seed, ginseng, etc.) for nutraceutical and functional food markets. Overlaps in standardized extract technology and global B2B distribution, though at a smaller scale.

TypeEmerging player
Description

US-based supplier of standardized botanical and herbal extracts to the dietary supplement industry with vertically integrated sourcing in India and Southeast Asia. Comparable in contract farming integration and B2B ingredient distribution model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries13 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance14 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sami-Sabinsa Group

Nutraceutical and Cosmeceutical Ingredientssami-sabinsagroup.com

Sami-Sabinsa Group is a Bangalore-headquartered, family-controlled manufacturer of standardized herbal extracts, nutraceuticals, cosmeceuticals, and specialty chemicals for the pharmaceutical, food, and personal care industries, serving global manufacturers across 19 countries via 14 wholly-owned subsidiaries and a 500+ patent portfolio.

What Sami-Sabinsa Group does

Sami-Sabinsa Group Limited is a Bangalore-headquartered, family-controlled manufacturer of standardized botanical extracts, nutraceuticals, cosmeceuticals, probiotics, enzymes, and specialty fine chemicals serving nutraceutical, pharmaceutical, cosmetic, and food & beverage manufacturers globally. The company's portfolio centers on patented, clinically documented branded ingredients—most prominently Curcumin C3 Complex (263+ publications, 109 clinical studies), BioPerine (95% piperine, 63 bioavailability studies), LactoSpore (GRAS-affirmed Heyndrickxia coagulans MTCC 5856), ForsLean, Gugulipid, Selenium SeLECT, Sabroxy, and Cosmoperine—protected by 500+ granted patents and 300+ pending applications across major jurisdictions. Sami-Sabinsa holds 100+ national and international awards including the 2024 Ellis Island Medal of Honor and the 2023 Varro E. Tyler Award from the American Botanical Council, reflecting its industry standing.

Operationally, Sami-Sabinsa runs eight cGMP-certified manufacturing facilities (seven in Karnataka and Telangana, India; one in Payson, Utah) and a 40,000-acre contract farming program across India, Southeast Asia, and Africa involving 5,000+ farmers under buyback agreements. Core technology platforms include Super Critical Fluid (CO2) Extraction at the Nelamangala Bengaluru facility, a continuous stainless-steel-316 extraction line at Dobaspet rated at 40+ tonnes/day of herbal raw material, and nine in-house R&D divisions (Natural Drugs, Phytochemistry, Synthetic Chemistry, Tissue Culture, Biotechnology, Analytical R&D, Biological Research, Microbiology, Formulation R&D) staffed by 120+ scientists. Certifications across ISO 22000, FSSC 22000, NSF GMP, USP GMP, FAMI-QS, Non-GMO Project, FSSAI, FSRN, and Halal/Kosher enable cross-jurisdictional regulatory access.

The company monetizes through a direct B2B sales model via 14 wholly-owned subsidiaries across 19 countries (USA, India, Australia, Brazil, Canada, China, Germany, Japan, Poland, South Africa, South Korea, UAE, Vietnam) with quote-based pricing and multi-year manufacturer contracts. Revenue streams include ingredient sales (nutraceutical and cosmeceutical), patent licensing of branded ingredients, cGMP contract manufacturing in India and the USA, and contract research services. The group was founded in 1991 by the late Dr. Muhammed Majeed (with Sabinsa Corporation founded in the USA in 1988) and is now led by Dr. Anju Majeed (Group Executive Chairperson) and Shaheen Majeed (Global CEO & MD), with ownership and control remaining within the Majeed family. The group rebranded from Sami Labs Limited to Sami-Sabinsa Group Limited in 2025 and acquired Nature's Formulary on 2025-02-04.

Sami-Sabinsa Group firmographics

Firmographics
Name
Sami-Sabinsa Group
Legal name
Sami-Sabinsa Group Limited
Website
https://sami-sabinsagroup.com
Company type
Private
Founded year
1991
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Sami-Sabinsa Group is a Bangalore-headquartered, family-controlled manufacturer of standardized herbal extracts, nutraceuticals, cosmeceuticals, and specialty chemicals for the pharmaceutical, food, and personal care industries, serving global manufacturers across 19 countries via 14 wholly-owned subsidiaries and a 500+ patent portfolio.
Ownership category
akta.pro rank

Sami-Sabinsa Group industry classification

Industry
Product category
Nutraceutical and Cosmeceutical Ingredients
NAICS
Medicinal and Botanical Manufacturing (325411), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin) (AFAJAKAK)
akta.pro secondary industry
Probiotics & Digestive Health Supplements (CRADAGAF)

Keywords

  • Standardized herbal extracts
  • Nutraceutical ingredients
  • Cosmeceutical actives
  • Probiotic postbiotic blends
  • Specialty fine chemicals

Where Sami-Sabinsa Group is headquartered

Location

Headquarters

HQ city
Bangalore
HQ country
India
HQ region
Asia

Offices16 records

Markets served

Sami-Sabinsa Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Nutraceutical Ingredients: Sale of standardized phyto extracts, enzymes, probiotics, prebiotics, postbiotics, minerals, and nutritional fine chemicals to dietary supplement manufacturers
  2. Cosmeceutical Ingredients: Supply of natural actives, peptides, anti-glycation ingredients, dermaceuticals, and nutricosmetics to personal care and cosmetics manufacturers
  3. Patent Licensing: Licensing of patented products and proprietary formulations including Curcumin C3 Complex, BioPerine, LactoSpore, ForsLean, and other branded ingredients
  4. Contract Manufacturing: Custom manufacturing services at cGMP certified facilities in India and USA for nutraceutical and pharmaceutical ingredients
  5. Contract Research Services: R&D services including synthesis, phytochemistry, biotechnology research, tissue culture, and analytical method development for external clients

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B bulk ingredient supply with custom formulation capabilities

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Sami-Sabinsa Group product offering

Product offering

Core offering

Sami-Sabinsa Group manufactures and markets standardized herbal extracts, nutraceutical and cosmeceutical ingredients (including Curcumin C3 Complex, BioPerine, LactoSpore, ForsLean, Boswellin), probiotics, postbiotics, enzymes, multi-enzyme blends, minerals, peptides, and specialty fine chemicals. It sells these patented, clinically validated ingredients to dietary supplement, pharmaceutical, food and beverage, and personal care manufacturers through its own direct sales network across 19 countries.

Product overview

Sami-Sabinsa Group is a research-focused multinational health science company that manufactures and markets a comprehensive portfolio of patented nutraceutical and cosmeceutical ingredients. The company's product ecosystem centers on its core offerings: Standardized Phyto Extracts (featuring flagship brands like Curcumin C3 Complex®, BioPerine®, ForsLean®, Boswellin®, Gugulipid®, and Shagandha™), complemented by Super Critical Fluid (SCF) Extracts using eco-friendly CO2 extraction technology, and a complete biotics portfolio including LactoSpore®, ImmunoSpore™, LactoWise®, and LactoCran® under the Prebiotics, Probiotics, Postbiotics & Synbiotics category. The company also offers Phyto Functional Blends (LeanGard®, HotSip®, LivLonga®, Metabolicgard®, NiLitis® SR, Selendrovir™, WithanAlpha™) that combine multiple patented ingredients for targeted health benefits, and the Geroceuticals™ line for healthy aging. Supporting these core products are Cosmeceutical Ingredients including Natural Actives, Peptides (Olepent®, Oletrip®), Anti-glycation, Dermaceuticals, Nutricosmetics, and Specialty Chemicals. The portfolio spans over 120 products across 8 manufacturing units, supported by Contract Farming services for sustainable raw material sourcing and Contract Research capabilities for custom development. Notable branded products include: Curcumin C3 Complex® (95% Curcuminoids, 263+ publications), BioPerine® (95% Piperine, bioavailability enhancer), LactoSpore® (spore-forming probiotic), Selenium SeLECT® (L-Selenomethionine), Boswellin® (Boswellia serrata extracts), ForsLean® (Coleus forskohlii, 10-40% Forskolin), Gugulipid® (Commiphora mukul), Shagandha™ (Ashwagandha), Saberry® (Amla/Emblica), Cococin® (Coconut), Silbinol® (Pterocarpus), and SabiWhite® (Tetrahydrocurcumin).

Differentiator

Problem solved

Functional benefit

Brands

  • Curcumin C3 Complex: Patented composition of curcuminoids from turmeric rhizomes, extensively studied with 263+ publications including 109 clinical studies
  • BioPerine
  • LactoSpore
  • Gugulipid
  • Boswellin
  • ForsLean
  • Saberry
  • Silbinol
  • Selenium SeLECT
  • Resvenox
  • Centellin
  • Nigellin
  • Shagandha
  • DigeZyme
  • Geroceuticals

Products and services

  • Standardized Phyto Extracts A comprehensive range of standardized herbal extracts including Curcumin C3 Complex®, BioPerine®, ForsLean®, Boswellin®, Gugulipid®, Shagandha™ and other botanical ingredients with standardized active compound concentrations for nutraceutical and pharmaceutical manufacturers.
  • Super Critical Fluid (SCF) Extracts Eco-friendly CO2-based botanical extracts including Nigellin® Black Cumin extracts, Ginger SCF Extract, Turmeric SCF Extract, and Guggul SCF Extract (Gugulipid®) with intact bio-potency for nutraceutical manufacturers.
  • Phytochemicals for Nutritional Use Pure phytochemical compounds including Calebin A (CurCousin™), Resveratrol (Resvenox®), Oxyresveratrol (OxyResvenox®), Forskolin Carbonate, Diindolylmethane (DIM), and Indole-3-Carbinol for functional nutrition applications.
  • Specialty Chemicals - Nutraceuticals Specialty fine chemicals including Eflornithine Hydrochloride, chiral drug intermediates, and custom synthesis for nutritional and pharmaceutical applications.
  • Nutritional Fine Chemicals Fine chemicals for nutritional applications including amino acid derivatives, specialized intermediates, and research chemicals.
  • Multi-enzyme Blends DigeZyme® and DigeZyme® EC enzyme blends combining α-Amylase, Cellulase, Lactase, Lipase, and Neutral protease for digestive health supplement manufacturers.
  • Prebiotics, Probiotics, Postbiotics & Synbiotics Complete biotics portfolio including LactoSpore® (Heyndrickxia coagulans MTCC 5856), ImmunoSpore™, LactoWise®, LactoCran®, FenuFibers®, Fenumannan®, and Starmeric® for gut health and microbiome support.
  • Minerals for Nutritional Use Bioavailable mineral compounds including Selenium SeLECT®, MethySelene®, SelenoForce®, Zinc Citrate, Zinc Monomethionine, Magnesium compounds, and Vanadium forms.
  • GRAS Affirmed Products Products with FDA Generally Recognized As Safe status including BioPerine®, Curcumin C3 Complex®, Citrin K®, Cococin™, LactoSpore®, Saberry®, Selenium SeLECT®, CurCousin™, and Curcumin C3 Reduct®.
  • Geroceuticals™ Healthy aging ingredient line including Shagandha™ (Ashwagandha), Nigellin® Black Cumin extracts, Bacopin® (Brahmi), Silbinol® (Pterocarpus), Sabroxy® (Oroxylum), Centellin® (Gotu Kola), and Tinofolin® (Guduchi) for longevity and cognitive health.
  • Phyto Functional Blends Proprietary combination products including LeanGard®, HotSip®, LivLonga®, Metabolicgard®, NiLitis® SR, OmegaMax, Selendrovir™, WithanAlpha™, and ZeaLutein® for targeted health benefits.
  • Natural Actives Cosmeceutical natural active ingredients including Saberry® (Amla), Boswellin® CG (Boswellia), Bacopin® (Brahmi), Centellin® CG (Gotu Kola), Venocin® (Horse Chestnut), Silbinol® (Pterocarpus), SabiWhite® (Tetrahydrocurcumin), and Cosmoperine® (Tetrahydropiperine).
  • Peptides Bioactive peptides including Olepent® (Oleanoyl sh-Pentapeptide-4), Oletrip® (Oleanoyl tripeptide), and PeptiSeLect® (Methylseleno Carboxypropylglutamine) for skin care and anti-aging applications.
  • Contract Farming Service Sustainable sourcing service through contract cultivation of medicinal plants across 40,000+ acres in India, Southeast Asia, and Africa, supporting Good Agricultural Practices and ensuring raw material quality supply for the group's manufacturing operations.
  • Contract Research Service Comprehensive R&D services including synthesis of organic molecules, chiral synthesis, SCFE, biotechnology research, phytochemistry, tissue culture, biochemical analysis, cosmetic claim substantiation, and pilot plant scale-up, offered in collaboration with IISc, IIT-Mumbai, IICT-Hyderabad, and UICT-Mumbai.

Quantifiable outcome

  • 500+ US and International patents awarded
  • +4 more outcomes

Companies that use Sami-Sabinsa Group

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Sami-Sabinsa Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Sami-Sabinsa Group partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered flagship, major, core and strategic.

  • The Hindu GroupflagshipGTM or Marketing Partner · 1 June 2026Sami-Sabinsa Group served as Presenting Partner for The Hindu Huddle on Campus event at Amity University Bengaluru and the main two-day The Hindu Huddle conclave. The partnership supports youth engagement platform focusing on contemporary issues and provides visibility for the company's brand in India.
  • Kerry Inc.majorStrategic or Co-development Partner · 1 May 2026Sami-Sabinsa Group and Kerry Inc. jointly challenged FSSAI advisory restricting use of Ashwagandha leaves in dietary supplements, filing petitions at Karnataka High Court. Both companies sought to quash the advisory that prohibited use of leaves and leaf extracts, arguing it required formal regulation amendment. The court granted interim relief staying the ban for both petitioners.
  • The Hindu GroupflagshipGTM or Marketing Partner · 1 May 2026Presenting Partner for The Hindu Huddle conference themed 'A World in Transition' bringing together ministers, ambassadors, MPs, and artists for discussions on geopolitics, AI, and democracy.
  • Indian FarmerscoreStrategic or Co-development PartnerContract farming partnerships with thousands of farmers across India, particularly in Tamil Nadu, Karnataka, and other states. Farmers receive planting supplies, training, buyback agreements, and guaranteed prices for cultivating medicinal plants. The model extends to Southeast Asian countries and Africa.
  • Princeton UniversitystrategicStrategic or Co-development PartnerSabinsa Corporation is an Industrial Associate Program (IAP) member of Princeton University, enabling access to sophisticated instruments including X-ray crystallography for research purposes.
  • IIT MumbaistrategicStrategic or Co-development PartnerCollaborative research partnerships with Indian Institute of Technology Mumbai for process and method development.
  • IICT HyderabadstrategicStrategic or Co-development PartnerCollaborative research with Indian Institute of Chemical Technology for key process development.
  • IISc BangalorestrategicStrategic or Co-development PartnerCollaborative research with Indian Institute of Science for advanced analytical capabilities and research support.
  • UICT MumbaistrategicStrategic or Co-development PartnerAcademic collaboration for research and development in pharmaceutical technology.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Sami-Sabinsa Group competitors and assessment

Company assessment

Direct peers

  • Indena S.p.A. Italian-based global leader in standardized botanical extracts and active pharmaceutical ingredients derived from plants. Directly comparable B2B ingredient manufacturer with a similar scientific, patented ingredient, and contract farming/procurement model.
  • OmniActive Health Technologies: Mumbai-headquartered supplier of carotenoids, botanical extracts, and specialty nutraceutical ingredients. Closest Indian peer with overlapping product categories (vision health, cognition, immunity) and similar branded-ingredient go-to-market model.
  • Martin Bauer Group: Germany-based global supplier of botanical extracts, tea, and plant-based ingredients for the food, beverage, nutraceutical, and pharmaceutical industries. Directly comparable in scale, scientific approach, and vertically integrated raw material sourcing.
  • Bio-Botanica: US-based manufacturer of botanical extracts serving the cosmetic, personal care, and nutraceutical markets. Comparable in standardized herbal extract offering and B2B ingredient distribution model, though smaller in scale.
  • Layn Natural Ingredients: China/US-based producer of high-purity botanical extracts and natural sweeteners (including stevia, monk fruit, and polyphenols) for nutrition and food applications. Directly comparable in standardized polyphenol extract manufacturing and global ingredient distribution.

Broad incumbents

  • Naturex (Givaudan): Now part of Givaudan, Naturex is a broad-based natural ingredients supplier across food, beverage, nutrition, and personal care. Broader portfolio than Sami-Sabinsa but overlapping in standardized plant extracts and nutraceutical actives.
  • Kemin Industries: Privately held US ingredient manufacturer serving animal nutrition, human nutrition, and personal care with proprietary molecules. Comparable in scientific differentiation and proprietary ingredient focus, though broader in end-market coverage.
  • Kerry Group: Ireland-headquartered global taste and nutrition company with a substantial nutraceutical ingredients business. Already a Sami-Sabinsa legal co-petitioner (Ashwagandha FSSAI case) and an overlapping competitor in functional food and supplement ingredients.

Emerging players

  • Hunan Sunfull Bio-tech: China-based producer of standardized botanical extracts (green tea, grape seed, ginseng, etc.) for nutraceutical and functional food markets. Overlaps in standardized extract technology and global B2B distribution, though at a smaller scale.
  • Cepham (Cepham Life Sciences): US-based supplier of standardized botanical and herbal extracts to the dietary supplement industry with vertically integrated sourcing in India and Southeast Asia. Comparable in contract farming integration and B2B ingredient distribution model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Sami-Sabinsa Group social profiles

Digital presence

Sami-Sabinsa Group compliance and trust

Trust signal

Compliance14 records

Sami-Sabinsa Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sami-Sabinsa Group leadership team

Management profile

Number of profiles

Profiles5 records

Sami-Sabinsa Group subsidiaries and ownership

Company hierarchy

Subsidiaries13 records

Sami-Sabinsa Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sami-Sabinsa Group M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sami-Sabinsa Group

What does Sami-Sabinsa Group do?

Sami-Sabinsa Group manufactures and markets standardized herbal extracts, nutraceutical and cosmeceutical ingredients (including Curcumin C3 Complex, BioPerine, LactoSpore, ForsLean, Boswellin), probiotics, postbiotics, enzymes, multi-enzyme blends, minerals, peptides, and specialty fine chemicals. It sells these patented, clinically validated ingredients to dietary supplement, pharmaceutical, food and beverage, and personal care manufacturers through its own direct sales network across 19 countries.

Is Sami-Sabinsa Group a public or private company?

Sami-Sabinsa Group is a private company. It is classified as family owned and is currently operating.

When was Sami-Sabinsa Group founded?

Sami-Sabinsa Group was founded in 1991. It employs 501 to 1,000 people.

Where is Sami-Sabinsa Group based?

Sami-Sabinsa Group is headquartered in Bangalore, India, in the Asia region.

How does Sami-Sabinsa Group make money?

Five revenue lines are on record. Nutraceutical Ingredients are the primary driver. The others are cosmeceutical Ingredients, patent Licensing, contract Manufacturing and contract Research Services.

Who are Sami-Sabinsa Group's main competitors?

Direct peers on record are Indena S.p.A., OmniActive Health Technologies, Martin Bauer Group, Bio-Botanica and Layn Natural Ingredients. Broad incumbents are Naturex (Givaudan), Kemin Industries and Kerry Group. Emerging players are Hunan Sunfull Bio-tech and Cepham (Cepham Life Sciences).

Does Sami-Sabinsa Group have an API?

No public API is recorded for Sami-Sabinsa Group.

What industry is Sami-Sabinsa Group in?

Sami-Sabinsa Group's product category is Nutraceutical and Cosmeceutical Ingredients. Its primary akta.pro industry code is AFAJAKAK, Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin), with a secondary code of CRADAGAF, Probiotics & Digestive Health Supplements. Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
nutritioninsight.comAshwagandha Standards Alliance opens global membership amid India regulatory scrutinyThe Ashwagandha Standards Alliance (ASA) has launched a global membership initiative to advance communication and standards for ashwagandha, responding to India's Food Safety and Standards Authority of India (FSSAI) and Ministry of AYUSH labeling all ashwagandha leaves as "adulterated" or "unsafe." The alliance, whose founding members include Sabinsa, Cepham, and Arjuna Naturals, supports an interim stay from the Karnataka High Court on FSSAI's attempt to restrict leaf use in commerce, arguing for science-based distinctions between adulteration and truthfully labeled ingredients. The ASA will focus on six priorities: safety, quality, education, analytical harmonization, transparency, and public trust.The Indian ExpressKarnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplementsThe Karnataka High Court stayed an advisory issued by the Food Safety and Standards Authority of India (FSSAI) that banned the use of Ashwagandha leaves or extracts in health supplements due to safety concerns flagged by the Union Ministry of Ayush. The interim order was granted in response to petitions filed by Sami-Sabinsa Group Ltd and Kerry Inc, which sought to quash the advisory. The stay applies only to the petitioners until the next date of hearing.The HinduMinisters, ambassadors, artists to join The Hindu’s Huddle in JuneThe Hindu Group is hosting its annual 'The Hindu Huddle' conference in Bengaluru on June 5-6, themed 'A World in Transition,' bringing together ministers, ambassadors, MPs, and artists for discussions on geopolitics, AI, democracy, and other contemporary issues. The presenting partner for the event is Sami-Sabinsa Group, with speakers including Union Ministers Hardeep Puri and Nitin Gadkari, various foreign ambassadors, and mental health advocates. The Hindu is also organizing mini-Huddle sessions in colleges ahead of the main event.EIN PresswireBoswellia Serrata Extract Market to Reach USD 1.65 Billion by 2036 on Clinical Backing & Aging DemandThe global Boswellia serrata extract market is projected to grow from USD 588.0 million in 2026 to USD 1.65 billion by 2036, expanding at a 10.4% CAGR, according to a strategic outlook by Future Market Insights. The report identifies clinical validation, standardized efficacy, and sustainability as key growth drivers, with India and China leading raw material production while North America remains a high-value consumer market. Notable strategic developments include recent acquisitions and capacity expansions by Sami-Sabinsa Group, Carbyne Equity Partners, and OmniActive to consolidate supply chains in the nutraceutical space.Cosmetics BusinessSami-Sabinsa Group mourns death of Director and CEOSami-Sabinsa Group announced the death of its Director and CEO VG Nair on 6 July from complications from Covid-19. The company said he played a significant role in establishing its consistency in supply, manufacturing and exports. Founder Dr Muhammed Majeed expressed condolences and said Nair will be deeply missed.PR NewswireGlobal $10+ Mn Ursolic Acid Markets, 2015-2020, 2020-2025F, 2030FThe global ursolic acid market is projected to grow from $7.62 million in 2020 to $10.34 million by 2025, primarily driven by increasing demand in the cosmetic sector. Major players in this market include Sabinsa, Sami Labs, and others, highlighting significant industry involvement. Additionally, despite growth prospects, concerns over side effects may pose challenges to market expansion.